癌患者の間で得られた能力向上の知識と関連因子:横断的な多センター研究
Heli Arffman1, Mervi Siekkinen2, Helena Leino-Kilpi3
1Department of Nursing Science, University of Turku, Turku, Finland.
まとめ
癌患者には 心理社会的,倫理的,財政的な テーマについて より良い教育が必要です 病気の詳細ではなく 社会人口学的要因が 知識の受容に影響し 福祉が重要な要因でした
科学分野:
- 腫瘍学
- 健康心理学
- 患者 の 教育
背景:
- 患者の知識を理解することは 効果的ながん治療に不可欠です
- 社会統計学,病気,心理的要因が知識の獲得に影響を与える可能性があります.
- 生活の質 (QOL) は癌の生存率の重要な結果です.
研究 の 目的:
- 癌患者の知識を分析する
- 受けた知識と患者因子の関連性を調べる.
- 受け取った知識と健康関連の生活の質 (QOL) の関係を探求する.
主な方法:
- 治療またはフォローアップ中の350人の癌患者の横断的多センター調査.
- 使用された検証されたスケール:病院患者の知識 (RKhp),一般的自己効率性スケール (GSE),ショート・ウォリック・エディンバーグ・メンタル・ウェルビーイングスケール (SWEMWBS),および15D QOLアンケート.
- データを分析するために多変数統計的方法を使用した.
主要な成果:
- 患者は生理学的,機能的,経験的な領域で最も多くの知識を受け,経済的,社会的,倫理的な側面では最も少ない.
- 高等教育,独身,就職は 知識の不足と関連していました
- ポジティブな精神的幸福度は,より高い知識と相関しており,自己効能やQOLとの関連は見つかりませんでした.
結論:
- 心理的,倫理的,財政的な領域に重点を置いた 患者の教育を強化する必要がある.
- 患者中心のケアには 個々の知識のニーズに対応することが不可欠です
- 発見はがん患者の教育を改善するための臨床実務と将来の研究を参考にします.
関連する概念動画
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
01:27Nursing Ethical Principles II
1.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.3K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:18Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K